Erratum: Glucocorticoids inhibit basal and hormone-induced serotonin synthesis in pancreatic beta cells. (PLOS ONE (2016)11:2 (E0149343)Doi: 10.1371/journal.pone.0149343);Glucocorticoids inhibit basal and hormone-induced serotonin synthesis in pancreatic beta cells

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Ebou, Moina Hasni ^a,b,c   Singh Estivalet, Amrit ^a,b,c   Launay, Jean Marie ^d   Callebert, Jacques ^d   Tronche, François ^b,e   Ferré, Pascal ^a,b,c   Gautier, Jean François ^a,b,c,d   Guillemain, Ghislaine ^a,b,c   Bréant, Bernadette ^a,b,c   Blondeau, Bertrand ^a,b,c   Riveline, Jean Pierre ^a,b,c,d  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

^e CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOCORTICOID RECEPTOR; LIRAGLUTIDE; PROLACTIN; SEROTONIN; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; TRYPTOPHAN HYDROXYLASE 2; UNCLASSIFIED DRUG; GLUCAGON LIKE PEPTIDE 1; GLUCOCORTICOID; PEPTIDE; VENOM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SYNTHESIS; HORMONE SYNTHESIS; IN VIVO STUDY; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; ANALOGS AND DERIVATIVES; ANIMAL; CELL LINE; DRUG EFFECTS; METABOLISM;

ANIMALS; CELL LINE; GLUCAGON-LIKE PEPTIDE 1; GLUCOCORTICOIDS; INSULIN-SECRETING CELLS; MICE; PEPTIDES; PROLACTIN; SEROTONIN; TRYPTOPHAN HYDROXYLASE; VENOMS;

EID: 84960539620     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0155174     Document Type: Erratum

References (40)

1. Pivonello R, De Leo M, Vitale P, Cozzolino A, Simeoli C, De Martino MC, et al. Pathophysiology of diabetes mellitus in Cushing's syndrome. Neuroendocrinology. 2010; 92 Suppl 1:77-81. Epub 2010/09/21 doi: 10.1159/000314319 [pii]. PMID: 20829623.
2. Resmini E, Minuto F, Colao A, Ferone D. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Acta Diabetol. 2009; 46(2):85-95. Epub 2009/03/27. doi: 10.1007/s00592-009-0112-9 PMID: 19322513.
3. Di Dalmazi G, Pagotto U, Pasquali R, Vicennati V. Glucocorticoids and type 2 diabetes: from physiology to pathology. J Nutr Metab. 2012; 2012:525093. Epub 2013/01/15. doi: 10.1155/2012/525093 PMID: 23316348; Pub Med Central PMCID: PMC3536319.
4. van Raalte DH, Ouwens DM, Diamant M. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest. 2009; 39(2):81-93. VANRAALTE2009.
5. Lambillotte C, Gilon P, Henquin JC. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest. 1997; 99(3):414-23. Epub 1997/02/01. doi: 10.1172/JCI119175 PMID: 9022074; Pub Med Central PMCID: PMC507814.
6. Weinhaus AJ, Bhagroo NV, Brelje TC, Sorenson RL. Dexamethasone counteracts the effect of prolactin on islet function: implications for islet regulation in late pregnancy. Endocrinology. 2000; 141 (4):1384-93. Epub 2000/04/04. doi: 10.1210/endo.141.4.7409 PMID: 10746642.
7. Adcock IM, Caramori G, Ito K. New insights into the molecular mechanisms of corticosteroids actions. Curr Drug Targets. 2006; 7(6):649-60. Epub 2006/06/22. PMID: 16787166.
8. Gremlich S, Roduit R, Thorens B. Dexamethasone induces posttranslational degradation of GLUT2 and inhibition of insulin secretion in isolated pancreatic beta cells. Comparison with the effects of fatty acids. J Biol Chem. 1997; 272(6):3216-22. Epub 1997/02/07. PMID: 9013557.
9. Ohneda M, Johnson JH, Inman LR, Unger RH. GLUT-2 function in glucose-unresponsive beta cells of dexamethasone-induced diabetes in rats. J Clin Invest. 1993; 92(4):1950-6. Epub 1993/10/01. doi: 10.1172/JCI116788 PMID: 8408647; Pub Med Central PMCID: PMC288361.
10. Borboni P, Porzio O, Magnaterra R, Fusco A, Sesti G, Lauro R, et al. Quantitative analysis of pancreatic glucokinase gene expression in cultured beta cells by competitive polymerase chain reaction. Mol Cell Endocrinol. 1996; 117(2):175-81. Epub 1996/03/25. 0303720795037454 [pii]. PMID: 8737377.
11. Ullrich S, Berchtold S, Ranta F, Seebohm G, Henke G, Lupescu A, et al. Serum- and glucocorticoidinducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion. Diabetes. 2005; 54(4):1090-9. Epub 2005/03/29. 54/4/1090 [pii]. PMID: 15793248.
12. Hamamdzic D, Duzic E, Sherlock JD, Lanier SM. Regulation of alpha 2-adrenergic receptor expression and signaling in pancreatic beta-cells. Am J Physiol. 1995; 269(1 Pt 1):E162-71. Epub 1995/07/01. PMID: 7631772.
13. Zawalich WS, Tesz GJ, Yamazaki H, Zawalich KC, Philbrick W. Dexamethasone suppresses phospholipase C activation and insulin secretion from isolated rat islets. Metabolism. 2006; 55(1):35-42. Epub 2005/12/06. S0026-0495(05)00273-8 [pii] doi: 10.1016/j.metabol.2005.06.023 PMID: 16324917.
14. Kim H, Toyofuku Y, Lynn FC, Chak E, Uchida T, Mizukami H, et al. Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med. 2010; 16(7):804-8. Epub 2010/06/29. nm.2173 [pii] doi: 10.1038/nm.2173 PMID: 20581837; Pub Med Central PMCID: PMC2921604.
15. Paulmann N, Grohmann M, Voigt JP, Bert B, Vowinckel J, Bader M, et al. Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol. 2009; 7(10): e1000229. Epub 2009/10/28. doi: 10.1371/journal.pbio.1000229 PMID: 19859528; Pub Med Central PMCID: PMC2760755.
16. El-Merahbi R, Loffler M, Mayer A, Sumara G. The roles of peripheral serotonin in metabolic homeostasis. FEBS Lett. 2015; 589(15):1728-34. Epub 2015/06/14. doi: 10.1016/j.febslet.2015.05.054 S0014-5793(15)00455-X [pii]. PMID: 26070423.
17. Jaim-Etcheverry G, Zieher LM. Electron microscopic cytochemistry of 5-hydroxytryptamine (5-HT) in the beta cells of guinea pig endocrine pancreas. Endocrinology. 1968; 83(5):917-23. Epub 1968/11/01 doi: 10.1210/endo-83-5-917 PMID: 4879454.
18. Nesan D, Vijayan MM. The transcriptomics of glucocorticoid receptor signaling in developing zebrafish. PLoS One. 2013; 8(11):e80726. Epub 2013/12/19. doi: 10.1371/journal.pone.0080726 PONE-D-13-22836 [pii]. PMID: 24348914; Pub Med Central PMCID: PMC3858477.
19. Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, et al. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology. 1990; 127(1):126-32. MIYAZAKI1990A. PMID: 2163307
20. Valtat B, Dupuis C, Zenaty D, Singh-Estivalet A, Tronche F, Breant B, et al. Genetic evidence of the programming of beta cell mass and function by glucocorticoids in mice. Diabetologia. 2011; 54(2):350-9. VALTAT2011. doi: 10.1007/s00125-010-1898-2 PMID: 20857084
21. Brouwers B, de Faudeur G, Osipovich AB, Goyvaerts L, Lemaire K, Boesmans L, et al. Impaired Islet Function in Commonly Used Transgenic Mouse Lines due to Human Growth Hormone Minigene Expression. Cell Metab. 2014; 20(6):979-90. Epub 2014/12/04. doi: 10.1016/j.cmet.2014.11.004 S1550-4131(14)00501-4 [pii]. PMID: 25470546.
22. Fransson L, Dos Santos C, Wolbert P, Sjoholm A, Rafacho A, Ortsater H. Liraglutide counteracts obesity and glucose intolerance in a mouse model of glucocorticoid-induced metabolic syndrome. Diabetol Metab Syndr. 2014; 6(1):3. Epub 2014/01/16. doi: 10.1186/1758-5996-6-3 [pii]. PMID: 24423471; Pub Med Central PMCID: PMC3905931.
23. Valtat B, Riveline JP, Zhang P, Singh-Estivalet A, Armanet M, Venteclef N, et al. Fetal PGC-1alpha overexpression programs adult pancreatic beta-cell dysfunction. Diabetes. 2013; 62(4):1206-16. Epub 2013/01/01. doi: 10.2337/db12-0314 [pii]. PMID: 23274887; Pub Med Central PMCID: PMC3609553.
24. Kema IP, Schellings AM, Hoppenbrouwers CJ, Rutgers HM, de Vries EG, Muskiet FA. High performance liquid chromatographic profiling of tryptophan and related indoles in body fluids and tissues of carcinoid patients. Clin Chim Acta. 1993; 221(1-2):143-58. Epub 1993/11/30. PMID: 7512001.
25. Khan IA, Thomas P. Disruption of neuroendocrine control of luteinizing hormone secretion by aroclor 1254 involves inhibition of hypothalamic tryptophan hydroxylase activity. Biol Reprod. 2001; 64 (3):955-64. Epub 2001/02/24. PMID: 11207213.
26. Herrera PL. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development. 2000; 127(11):2317-22. Epub 2000/05/11. PMID: 10804174.
27. Tronche F, Kellendonk C, Reichardt HM, Schutz G. Genetic dissection of glucocorticoid receptor function in mice. Curr Opin Genet Dev. 1998; 8(5):532-8. Epub 1998/10/31. S0959-437X(98)80007-5 [pii]. PMID: 9794823.
28. Clark JA, Flick RB, Pai LY, Szalayova I, Key S, Conley RK, et al. Glucocorticoid modulation of tryptophan hydroxylase-2 protein in raphe nuclei and 5-hydroxytryptophan concentrations in frontal cortex of C57/Bl6 mice. Mol Psychiatry. 2008; 13(5):498-506. Epub 2007/07/12. 4002041 [pii] doi: 10.1038/sj. mp.4002041 PMID: 17622221; Pub Med Central PMCID: PMC3392182.
29. Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 2008; 31(9):464-8. Epub 2008/08/05. doi: 10.1016/j.tins.2008.06.006 S0166-2236(08)00164-1 [pii]. PMID: 18675469.
30. Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry. 2000; 61 Suppl 6:4-6. Epub 2000/04/25. PMID: 10775017.
31. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010; 33(2):414-20. Epub 2009/11/17 doi: 10.2337/dc09-1124 dc09-1124 [pii]. PMID: 19910503; Pub Med Central PMCID: PMC2809295.
32. Schraenen A, Lemaire K, de Faudeur G, Hendrickx N, Granvik M, Van Lommel L, et al. Placental lactogens induce serotonin biosynthesis in a subset of mouse beta cells during pregnancy. Diabetologia. 2010; 53(12):2589-99. Epub 2010/10/13. doi: 10.1007/s00125-010-1913-7 PMID: 20938637; Pub Med Central PMCID: PMC2974930.
33. Gesina E, Tronche F, Herrera P, Duchene B, Tales W, Czernichow P, et al. Dissecting the role of glucocorticoids on pancreas development. Diabetes. 2004; 53(9):2322-9. GESINA2004. PMID: 15331541
34. Protzek AO, Costa-Junior JM, Rezende LF, Santos GJ, Araujo TG, Vettorazzi JF, et al. Augmented beta-Cell Function and Mass in Glucocorticoid-Treated Rodents Are Associated with Increased Islet Irbeta/AKT/mTOR and Decreased AMPK/ACC and AS160 Signaling. Int J Endocrinol. 2014; 2014:983453. Epub 2014/10/15. doi: 10.1155/2014/983453 PMID: 25313308; Pub Med Central PMCID: PMC4182854.
35. Xu G, Stoffers DA, Habener JF, Bonner-Weir S. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes. 1999; 48(12):2270-6. Epub 1999/12/02. PMID: 10580413.
36. Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PC. Marked Expansion of Exocrine and Endocrine Pancreas with Incretin Therapy in Humans with increased Exocrine Pancreas Dysplasia and the potential for Glucagon-producing Neuroendocrine Tumors. Diabetes. 2013. Epub 2013/03/26. db12-1686 [pii] doi: 10.2337/db12-1686 PMID: 23524641.
37. van Raalte DH, van Genugten RE, Linssen MM, Ouwens DM, Diamant M. Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans. Diabetes Care. 2011; 34(2):412-7. Epub 2011/01/11. dc10-1677 [pii] doi: 10.2337/dc10-1677 PMID: 21216851; Pub Med Central PMCID: PMC3024359.
38. Brunetti L, Orlando G, Recinella L, Leone S, Ferrante C, Chiavaroli A, et al. Glucagon-like peptide 1 (7-36) amide (GLP-1) and exendin-4 stimulate serotonin release in rat hypothalamus. Peptides. 2008; 29 (8):1377-81. Epub 2008/05/27. doi: 10.1016/j.peptides.2008.04.007 S0196-9781(08)00180-0 [pii]. PMID: 18502539.
39. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci U S A. 1987; 84(10):3434-8. Epub 1987/05/01. PMID: 3033647; Pub Med Central PMCID: PMC304885.
40. Garcia-Osta A, Del Rio J, Frechilla D. Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rat frontal cortex but not in the hippocampus. Brain Res Mol Brain Res. 2004; 126(2):181-7. Epub 2004/07/14. doi: 10.1016/j.molbrainres.2004.04.006 S0169328X04001950 [pii]. PMID: 15249142.